Artificial Skin Therapies; Strategy for Product Development
Advances in Wound Care · 2023
DOI: 10.1089/wound.2022.0050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Wound Care, 2023. Verfasst von Nephelie Vaporidou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgery and Interdisciplinary Sciences, University College London, London, United Kingdom. Hauptthemen laut MEDLINE: Skin, Artificial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 179 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Surgery and Interdisciplinary Sciences, University College London, London, United Kingdom.
- Oxartis Ltd., Oxford, United Kingdom.
- MADE Cymru, University of Wales Trinity Saint David, Swansea, Wales, United Kingdom.
- Research Strategy and Development, University College London, London, United Kingdom.
ORCID-Profile: Anna Restelli, Julian F Dye
Zitieren
APA
Vaporidou, N., Peroni, F., Restelli, A., Jalil, M. N., & Dye, J. F. (2023). Artificial Skin Therapies; Strategy for Product Development. Advances in Wound Care. https://doi.org/10.1089/wound.2022.0050
Vancouver
Vaporidou N, Peroni F, Restelli A, Jalil MN, Dye JF. Artificial Skin Therapies; Strategy for Product Development. Advances in Wound Care. 2023. doi:10.1089/wound.2022.0050
BibTeX
@article{Vaporidou2023,
author = {Vaporidou, Nephelie and Peroni, Federica and Restelli, Anna and Jalil, M Nauman and Dye, Julian F},
title = {Artificial Skin Therapies; Strategy for Product Development},
journal = {Advances in Wound Care},
year = {2023},
doi = {10.1089/wound.2022.0050}
}
EUVIMED